Sartorius Stedim Biotech Completes Acquisition of Chromatography Division of Novasep

Sartorius Stedim Biotech, a top partner of the biopharmaceutical industry announced that, the company has now closed the acquisition of the chromatography division of the company ‘Novasep’ and the acquisition has been followed the approval from the Federal Trade Commission of the United States. The business that has been acquired has generated the sales of […]

Continue Reading

EdiGene and Arbor Biotechnologies Partnered to Advance Programs for Ex Vivo Engineered Cell Therapy

EdiGene, a biotechnology company that is focused on the translation of the gene-editing technologies into the transformative therapies for the patients suffering from cancer and different genetic disorders has partnered with Arbor Biotechnologies, a biotechnology company developing and discovering the next generation of the genetic medicines for the purpose of accessing the proprietary CRISPR gene […]

Continue Reading

BioHeuris and Agldea Partnered to Launch a Joint platform for Agile Breeding Services

Agldea, a company in the services of applied research with the company’s headquarters in the regions including Pergamino, in Buenos Aires in Argentina, Missouri in USA, and Uruguay and the company ‘BioHeuris’, which has been a biotechnology startup company developing the integrated solutions for crop management through the process if gene editing and synthetic biology […]

Continue Reading

Pasithea Therapeutics Offers Two-pronged Approach in Psychiatric Disease Treatment

Pasithea Therapeutics, a biotechnology company based in Florida, the United States, has been striving to discover the new and advanced treatments for the neurological and mental disorders along with establishing the psychiatric clinic both in the United States and the United Kingdom for the purpose of offering the services of Ketamine Infusion. The company said […]

Continue Reading